| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Instituto Valenciano de Infertilidad, Spain |
| Information provided by: | Instituto Valenciano de Infertilidad, Spain |
| ClinicalTrials.gov Identifier: | NCT00455949 |
Purpose
Analyze the possible effect of the progesterone levels of the hCG administration on the oocyte embryo quality. The primary endpoint of this study is the pregnancy rate.
| Condition |
|
Premature Luteinization |
| Study Type: | Observational |
| Study Design: | Longitudinal, Defined Population, Prospective Study |
Eligibility
| Ages Eligible for Study: | 18 Years to 34 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Spain | |||||
| Instituto Valenciano de la Infertilidad | |||||
| Valencia, Spain, 46015 | |||||
| Instituto Valenciano de Infertilidad, Spain |
| Principal Investigator: | Marco Melo, MD | Instituto Valenciano de Infertilidad |
| Principal Investigator: | Marco Melo, MD | Instituto Valenciano de Infertilidad |
More Information
| Study ID Numbers: | VLC-MM-0106-307-14 |
| First Received: | April 3, 2007 |
| Last Updated: | April 3, 2007 |
| ClinicalTrials.gov Identifier: | NCT00455949 |
| Health Authority: | Spain: Ministry of Health |
|
